NEW YORK CITY, NY / ACCESS Newswire / November 1, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Jefferies Financial Group Inc. ("Jefferies" or the "Company") (NYSE:JEF). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Jefferies and certain of its officers […]
NEW YORK CITY, NY / ACCESS Newswire / November 1, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Protalix BioTherapeutics, Inc. ("Protalix" or the "Company") (NYSE:PLX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Protalix and certain of its officers and/or
NEW YORK CITY, NY / ACCESS Newswire / November 1, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Amer Sports, Inc. ("Amer" or the "Company") (NYSE:AS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Amer and certain of its officers and/or
NEW YORK CITY, NY / ACCESS Newswire / November 1, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Varonis Systems, Inc. ("Varonis" or the "Company") (NASDAQ:VRNS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Varonis and certain of its officers and/or
NEW YORK CITY, NY / ACCESS Newswire / November 1, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Sonic Automotive, Inc. ("Sonic Automotive" or the "Company") (NYSE:SAH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Sonic Automotive and certain of its
NEW YORK CITY, NY / ACCESS Newswire / November 1, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Larimar Therapeutics, Inc.("Larimar" or the "Company") (NASDAQ:LRMR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Larimar and certain of its officers and/or directors
Pomerantz LLP is investigating claims on behalf of investors of American Battery Technology Company ("American Battery" or the "Company") (NASDAQ:ABAT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether American Battery and certain of its officers and/or directors have engaged in securities fraud or other unlawful
NEW YORK CITY, NY / ACCESS Newswire / November 1, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Jumia Technologies AG ("Jumia" or the "Company") (NYSE:JMIA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Jumia and certain of its officers and/or
NEW YORK CITY, NY / ACCESS Newswire / November 1, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Enphase Energy, Inc. ("Enphase" or the "Company") (NASDAQ:ENPH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Enphase and certain of its officers and/or
NEW YORK CITY, NY / ACCESS Newswire / November 1, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Skye Bioscience, Inc. ("Skye" or the "Company") (NASDAQ:SKYE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Skye and certain of its officers and/or